Cite

HARVARD Citation

    Trad, R. et al. (2022). Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia. Journal for immunotherapy of cancer. 10 (7), p. . [Online]. 
  
Back to record